ASCP 2025

ASCP 2025 provides an authoritative mobile companion for attendees and professionals interested in the ASCP Annual Meeting on psychopharmacology. The app highlights the meeting’s focus on neuropsychiatric drug development and organizes information about discussions on diagnostic changes and the shift toward personalized interventions guided by biomarkers or genetic information. It outlines who is directing the program and how submissions are reviewed, helping users follow regulatory, academic, and industry perspectives. If you monitor advances in psychopharmacology or regulatory strategy, ASCP 2025 makes the meeting’s priorities and leadership more accessible.

Key Features

⭐ Official guide to ASCP 2025 themes and participating institutions.

⭐ Summaries of meeting topics such as diagnostic changes and biomarker-driven personalized interventions.

⭐ Profiles of the Program Committee and Review Subcommittee leadership and roles.

⭐ Overview of contributions from regulatory bodies and research agencies including FDA, EMA, and NIH institutes.

⭐ Information on industry engagement and the newly launched Industry Advisory Council.

Advantages

✅ Centralizes context on neuropsychiatric drug development discussions in one place.

✅ Clarifies who is setting the meeting agenda and the review process for submissions.

✅ Highlights cross-sector perspectives from academia, regulators, and industry for informed follow-up.

✅ Useful for professionals tracking regulatory trends and personalized intervention strategies.

Disadvantages

❎ Content is focused on the Annual Meeting and its leadership rather than general educational materials.

❎ Primarily relevant to specialists in psychopharmacology, regulatory affairs, and related fields.

Development Team

The ASCP 2025 Program Committee is chaired by Drs. Mark Rapaport and Tiffany Farchione and includes representatives from the ASCP community, FDA, EMA, NIMH, NIDA, NIAAA, and academia to guide the meeting direction. The Review Subcommittee, led by Drs. Manish Jha and Carlos Blanco, oversees program submission review. To represent industry perspectives, the ASCP Industry Advisory Council is led by Drs. Ross Baker and Julie Adams.